Congratulations to former Humanigen Board member Kevin Xie and Gracell Biotech. "AstraZeneca to buy China's Gracell Biotechnologies in $1.2 billion deal By Urvi Manoj Dugar and Christy Santhosh December 26, 20237:17 AM CST" https://www.reuters.com/markets/deals/aztrazeneca-buy-china-based-gracell-biotechnologies-12-bln-deal-2023-12-26/#:~:text=Dec%2026%20(Reuters)%20%2D%20AstraZeneca,world's%20second%2Dlargest%20pharmaceuticals%20market. My question regarding Gracell has been if lenzilumab has enhanced the safety and efficacy of their CAR-T therapy.